Search results

Source:

NHS England (Remove filter)

Published by NHS England, 04 November 2020

Sapropterin is not recommended to be available as a treatment option through routine commissioning for phenylketonuria because though there is sufficient evidence to commission this treatment, ...

Read Summary

Type:

Policy and Strategy (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 04 November 2020

Twice a financial year, NHS England makes decisions on which new specialised treatments should be routinely commissioned. Treatments are grouped into 5 levels of priority; those with highest relative...

Read Summary

Type:

Policy and Strategy (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 29 October 2020

NHS England has considered the evidence submitted as part of a Preliminary Policy Proposal to establish the Clinical Commissioning Policy Statement and have concluded that there is not enough...

Read Summary

Type:

Policy and Strategy (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 20 October 2020

In response to the public health emergency posed by COVID-19, NHS England and NHS Improvement, have set out the interim clinical commissioning position for passive immunisation with palivizumab...

Read Summary

Type:

Policy and Strategy (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 23 October 2020

NHS England will reimburse the use of generic PrEP (tenofovir disoproxil and emtricitabine) for eligible individuals as per the 2018 BHIVA recommendations within approved local authority commissioned...

Read Summary

Type:

Policy and Strategy (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 07 January 2021

This updated version now reflects guidance published by JCVI on 30 December 2020, covering the approval of the Oxford/AstraZeneca vaccine and, for both Pfizer/BioNTech and Oxford/AstraZeneca...

Read Summary

Type:

Policy and Strategy (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 24 November 2020

This letter to approved nominations for sites to deliver COVID-19 vaccinations outlines more information about the next steps that need to be undertaken, including confirmation of CCG and PCN leads, ...

Read Summary

Type:

Medicines Current Awareness (Remove filter)

Source:

Royal Pharmaceutical Society (Remove filter)

Published by Royal Pharmaceutical Society, 24 November 2020

Survey has highlighted the mental health difficulties faced by pharmacists every day, and noted COVID-19 pandemic has amplified the pressures, with 54% of pharmacists believing it had impacted their...

Read Summary

Type:

Medicines Current Awareness (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 04 December 2020

A further 11 areas of the country will be formally designated “integrated care systems” from April 2021, taking the total to 29 (covering 60% of the population in England). The remaining 13 areas are...

Read Summary

Type:

Medicines Current Awareness (Remove filter)

Source:

NHS England (Remove filter)

Published by NHS England, 24 November 2020

This document, building on previous proposals, opens up a discussion about how integrated care systems (ICS) could be embedded in legislation. One proposal is to establish ICS as NHS bodies by...

Read Summary

Type:

Medicines Current Awareness (Remove filter)